🇺🇸 FDA
Patent

US 8674118

Compounds and methods for the treatment or prevention of flavivirus infections

granted A61PA61P1/16A61P31/12

Quick answer

US patent 8674118 (Compounds and methods for the treatment or prevention of flavivirus infections) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P1/16, A61P31/12, A61P31/14, A61P37/02